Zydus Cadila may soon seek emergency use authorization (EUA) for its DNA-plasmid technology-based Covid-19 vaccine from the Drug Controller General of India. If approved, this would be the world's first DNA-plasmid vaccine.
Since the company has already conducted trials on age groups 12-18, this could also be India's first vaccine for children.Even as experts say that the children rarely develop severe forms of Covid-19, the states of Karnataka and Maharashtra have recently witnessed a spike in paediatric Covid cases, and some deaths too. Not only instances of coronavirus, but cases of paediatric black fungus were also reported in the past two months.
After the second wave wreaked havoc across India, Experts believe that vaccines are the best way forward for India, which launched its mass inoculation program in January. Since then, official data showed that only 11% of the population has received at least one vaccine dose while just 3.4% have completed the required two doses. While India's urban population that bore the brunt of overwhelmed health infrastructure during the second wave has been actively getting jabs but the authorities face a serious challenge in inoculating its rural population.
However, some studies, including lab-based work and analysis of real-world data, have suggested current Covid vaccines are somewhat less effective against the Delta variant than the Alpha variant. The experts also claim that the "vaccines protect, and a second dose is very important against the Delta variant", reported The Guardian.
Read More:: สมัครjoker